Electrophysiological correlates of intermediate syndrome following acute organophosphate poisoning

Clinical Toxicology

Volumn 47, Issue 3, 2009, Pages 193-205

  Jayawardane, Pradeepa ^a,b   Senanayake, Nimal ^a   Dawson, Andrew ^a  

^a UNIVERSITY OF PERADENIYA   (Sri Lanka)

^b UNIVERSITY OF SRI JAYEWARDENEPURA   (Sri Lanka)

Author keywords

Intermediate syndrome; Organophosphate; Poisoning

Indexed keywords

NICOTINIC RECEPTOR; ORGANOPHOSPHATE; INSECTICIDE;

ACETYLCHOLINE RELEASE; DISEASE COURSE; ELECTRODIAGNOSIS; ELECTROPHYSIOLOGY; FEEDBACK SYSTEM; HUMAN; INTERMEDIATE SYNDROME; INTOXICATION; MEDICAL RESEARCH; MUSCLE WEAKNESS; NERVE STIMULATION; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT CARE; RESPIRATORY FAILURE; RESPIRATORY FUNCTION; REVIEW; SCHWANN CELL; SYNDROME; ACTION POTENTIAL; ACUTE DISEASE; ANIMAL; DRUG EFFECT; META ANALYSIS; PATHOLOGY; SYNAPSE; SYNAPTIC TRANSMISSION; TOXICITY AND INTOXICATION;

ACTION POTENTIALS; ACUTE DISEASE; ANIMALS; ELECTROPHYSIOLOGY; HUMANS; INSECTICIDES; NEUROMUSCULAR JUNCTION; NEUROTOXICITY SYNDROMES; PHOSPHORIC ACID ESTERS; SCHWANN CELLS; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 64049104218     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650902832608     Document Type: Review

References (70)

1. Karalliedde L, Senanayake N. Acute organophosphorus insecticide poisoning in Sri Lanka. Forensic Sci Int 1988; 36:97-100. (Pubitemid 18007486)
2. Langley R, Sumner D. Pesticide mortality in the United States 1979- 1998. Vet Hum Toxicol 2002; 44:101-105.
3. Buckley NA, Roberts D, Eddleston M. Overcoming apathy in research on organophosphate poisoning. BMJ 2004; 329:1231-1233.
4. Buckley NA, Karalliedde L, Dawson A, Senanayake N, Eddleston M. Where is the evidence for treatments used in pesticide poisoning? Is clinical toxicology fiddling while the developing world burns? J Toxicol Clin Toxicol 2004; 42:113-116.
5. Lotti M, Becker CE, Aminoff MJ. Organophosphate polyneuropathy: pathogenesis and prevention. Neurology 1984; 34:658-662.
6. Lotti M, Moretto A, Capodicasa E, Bertolazzi M, Peraica M, Scapellato ML. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy. Toxicol Appl Pharmacol 1993; 122:165-171.
7. Senanayake N, Jeyaratnam J. Toxic polyneuropathy due to gingili oil contaminated with tri-cresyl phosphate affecting adolescent girls in Sri Lanka. Lancet 1981; 1:88-89.
8. Senanayake N. Tri-cresyl phosphate neuropathy in Sri Lanka: A clinical and neurophysiological study with a three year follow up. J Neurol Neurosurg Psychiatry 1981; 44:775-780.
9. Senanayake N, Karalliedde L. Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome. N Engl J Med 1987; 316:761-763.
10. Eddleston M, Mohamed F, Davies JO, Eyer P, Worek F, Sheriff MH, Buckley NA. Respiratory failure in acute organophosphorus pesticide self-poisoning. QJM 2006; 99:513-522.
11. He F, Xu H, Qin F, Xu L, Huang J, He X. Intermediate myasthenia syndrome following acute organophosphates poisoning-an analysis of 21 cases. Hum Exp Toxicol 1998; 17:40-45.
12. Singh G, Sidhu UP, Mahajan R, Avasthi G, Whig J. Phrenic nerve conduction studies in acute organophosphate poisoning. Muscle Nerve 2000; 23:627-632.
13. Jayawardane P, Dawson AH, Weerasinghe V, Karalliedde L, Buckley NA, Senanayake N. The spectrum of intermediate syndrome following acute organophosphate poisoning: A prospective cohort study from Sri Lanka. PLoS Med 2008; 5:e147.
14. Avasthi G, Singh G. Serial neuro-electrophysiological studies in acute organophosphate poisoning: correlation with clinical findings, serum cholinesterase levels and atropine dosages. J Assoc Physicians India 2000; 48:794-799.
15. Sedgwick EM, Senanayake N. Pathophysiology of the intermediate syndrome of organophosphorus poisoning. J Neurol Neurosurg Psychiatry 1997; 62:201-202.
16. Karalliedde L, Henry JA. Effects of organophosphates on skeletal muscle. Hum Exp Toxicol 1993; 12:289-296.
17. De Bleecker J, Van den Neucker K, Colardyn F. Intermediate syndrome in organophosphorus poisoning: A prospective study. Crit Care Med 1993; 21:1706-1711.
18. Benson B, Tolo D, Mclntire M. Is intermediate syndrome in organophosphate poisoning the result of insufficient oxime therapy? J Toxicol Clin Toxicol 1992; 30:347-349.
19. Benson B, Tolo D, Mclntire M. Is intermediate syndrome in organophophate poisoning the result of insufficient oxime therapy. Clin Toxicol 1992; 30:347-349.
20. John M, Oommen A, Zachariah A. Muscle injury in organophosphorous poisoning and its role in the development of intermediate syndrome. Neurotoxicology 2003; 24:43-53.
21. Dandapani M, Zachariah A, Kavitha MR, Jeyaseelan L, Oommen A. Oxidative damage in intermediate syndrome of acute organophosphorous poisoning. Indian J Med Res 2003; 117:253-259.
22. Katz EJ, Cortes IV, Eldefrawi EM, Eldefrawi AT. Chlorpyrifos, parathion, and their oxons bind to and desensitize a nicotinic acetylcholine receptor: relevance to their toxicities. Toxicol Appl Pharmacol 1997; 146:227-236.
23. De Bleecker J, Volgelaers D, Ceutericl C, Van Den Neucker K, Williems J, De Reuk J. Intermediate syndrome due to prolonged parathion poisoning. Acta Neurol Scand 1992; 86:421-424.
24. De Bleecker J, Lison D, Van Den Abeele K, Willems J, De Reuck J. Acute and subacute organophosphate poisoning in the rat. Neurotoxicology 1994; 15:341-348.
25. Besser R, Gutman L, Weilemann LS. Inactivation of end-plate acetylcholinesterase during the course of organophosphate intoxications. Arch Toxicol 1989; 63:412-415.
26. Besser R, Gutmann L, Dillmann U, Weilemann LS, Hopf HC. Endplate dysfunction in acute organophosphate intoxication. Neurology 1989; 39:561-567.
27. Besser R, Gutmann L. A quantitative study of the pancuronium antagonism at the motor endplate in human organophosphorus intoxication. Muscle Nerve 1995; 18:956-960.
28. Besser R, Vogt T, Gutmann L. Pancuronium improves the neuromuscular transmission defect of human organophosphate intoxication. Neurology 1990; 40:1275-1277.
29. De Bleecker J, Van den Abeele K, De Reuck J. Electromyography in relation to end-plate acetylcholinesterase in rats poisoned by different organophosphates. Neurotoxicology 1994; 15:331-340.
30. Dongren Y, Tao L, Fengsheng H. Electroneurophysiological studies in rats of acute dimethoate poisoning. Toxicol Lett 1999; 107:249-254.
31. Seagar M, Leveque C, Charvin N, Marqueze B, Martin-Moutot N, Boudier JA, Boudier JL, Shoji-Kasai Y, Sato K, Takahashi M. Interactions between proteins implicated in exocytosis and voltage-gated calcium channels. Philos Trans R Soc Lond B Biol Sci 1999; 354:289-297.
32. Sudhof TC. The synaptic vesicle cycle. Annu Rev Neurosci 2004; 27:509-547.
33. Auld DS, Robitaille R. Perisynaptic Schwann cells at the neuromuscular junction: nerve- and activity-dependent contributions to synaptic efficacy, plasticity, and reinnervation. Neuroscientist 2003; 9:144-157.
34. Koirala S, Reddy LV, Ko CP. Roles of glial cells in the formation, function, and maintenance of the neuromuscular junction. J Neurocytol 2003; 32:987-1002. (Pubitemid 39011274)
35. Hughes BW, Kusner LL, Kaminski HJ. Molecular architecture of the neuromuscular junction. Muscle Nerve 2006; 33:445-461.
36. Massoulie J, Bon S. The molecular forms of cholinesterase and acetylcholinesterase in vertebrates. Annu Rev Neurosci 1982; 5:57-106.
37. Massoulie J, Anselmet A, Bon S, Krejci E, Legay C, Morel N, Simon S. The polymorphism of acetylcholinesterase: post-translational processing, quaternary associations and localization. Chem Biol Interact 1999; 119-120:29-42.
38. Wood SJ, Slater CR. The contribution of postsynaptic folds to the safety factor for neuromuscular transmission in rat fast- and slow-twitch muscles. J Physiol 1997; 500(Pt 1):165-176.
39. Wood SJ, Slater CR. Safety factor at the neuromuscular junction. Prog Neurobiol 2001; 64:393-429.
40. Karalliedde L, Baker D, Marrs TC. Organophosphate-induced intermediate syndrome: Aetiology and relationships with myopathy. Toxicol Rev 2006; 25:1-14.
41. Birks RI. The role of sodium ions in the metabolism of acetylcholine. Can J Biochem Physiol 1963; 41:2573-2597.
42. Richards DA, Guatimosim C, Rizzoli SO, Betz WJ. Synaptic vesicle pools at the frog neuromuscular junction. Neuron 2003; 39:529-541.
43. Rizzoli SO, Betz WJ. The structural organization of the readily releasable pool of synaptic vesicles. Science 2004; 303:2037-2039.
44. Boonyapisit K, Kaminski HJ, Ruff RL. Disorders of neuromuscular junction ion channels. Am J Med 1999; 106:97-113.
45. Van der Kloot W. Loading and recycling of synaptic vesicles in the Torpedo electric organ and the vertebrate neuromuscular junction. Prog Neurobiol 2003; 71:269-303.
46. Bowman WC, Prior C, Marshall IG. Presynaptic receptors in the neuromuscular junction. Ann N Y Acad Sci 1990; 604:69-81.
47. Bowman WC. Neuromuscular block. Br J Pharmacol 2006; 147(Suppl 1):S277-286.
48. Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol Rev 2003; 22:165-190.
49. Burgen AS. The mechanism of action of anticholinesterase drugs. Br J Pharmacol Chemother 1949; 4:219-228.
50. Janz H, Brons D, Warringa M. Chemical nature of DFP binding site of pseudocholinesterase. Biochim Biophys Acta 1959; 34:573-575.
51. De Bleecker J, Willems J, Van Den Neucker K, De Reuck J, Vogelaers D. Prolonged toxicity with intermediate syndrome after combined parathion and methyl parathion poisoning. J Toxicol Clin Toxicol 1992; 30:333-345; discussion 347-349.
52. De Bleecker J, Van Den Neucker K, Willems J. The intermediate syndrome in organophosphate poisoning: presentation of a case and review of the literature. J Toxicol Clin Toxicol 1992; 30:321-329; discussion 331-332.
53. De Bleecker JL. Intermediate syndrome: prolonged cholinesterase inhibition. J Toxicol Clin Toxicol 1993; 31:197-199.
54. De Bleecker JL. Multiple system organ failure: link to intermediate syndrome indirect. J Toxicol Clin Toxicol 1996; 34:249-250.
55. Sanders DB, Stalberg EV. AAEM minimonograph #25: single-fiber electromyography. Muscle Nerve 1996; 19:1069-1083.
56. Meriggioli MN, Sanders DB. Myasthenia gravis: diagnosis. Semin Neurol 2004; 24:31-39.
57. Maselli R, Jacobsen JH, Spire JP. Edrophonium: An aid in the diagnosis of acute organophosphate poisoning. Ann Neurol 1986; 19:508-510.
58. Heffron PF, Hobbiger F. Relationship between inhibition of acetylcholinesterase and response of the rat phrenic nerve-diaphragm preparation to indirect stimulation at higher frequencies. Br J Pharmacol 1979; 66:323-329.
59. Maselli RA, Soliven BC. Analysis of the organophosphate-induced electromyographic response to repetitive nerve stimulation: paradoxical response to edrophonium and D-tubocurarine. Muscle Nerve 1991; 14:1182-1188.
60. Maselli RA, Leung C. Analysis of neuromuscular transmission failure induced by anticholinesterases. Ann N Y Acad Sci 1993; 681:402-404. (Pubitemid 23233857)
61. Besser R, Wessler I, Gutmann L. Analysis of the organophosphateinduced electromyographic response to repetitive nerve stimulation: two types of end-plate depolarization account for the two most common patterns of decrement. Muscle Nerve 1992; 15:1369-1371.
62. Maselli R, Soliven B. Analysis of the organophosphate-induced electromyographic response to repetitive nerve stimulation: two types of end-plate depolarization account for the two most common patterns of decrement (A Reply). Muscle Nerve 1992; 15:1370-1371.
63. Besser R, Vogt T, Gutmann L, Hopf HC, Wessler I. Impaired neuromuscular transmission during partial inhibition of acetylcholinesterase: the role of stimulus-induced antidromic backfiring in the generation of the decrement-increment phenomenon. Muscle Nerve 1992; 15:1072-1080.
64. Randic M, Straughan DW. Antidromic activity in the rat phrenic nervediaphragm preparation. J Physiol 1964; 173:130-148.
65. Maselli RA, Leung C. Analysis of anticholinesterase-induced neuromuscular transmission failure. Muscle Nerve 1993; 16:548-553. (Pubitemid 23138104)
66. Wadia RS, Sadagopan C, Amin RB, Sardesai HV. Neurological manifestations of organophosphorus insecticide poisoning. J Neurol Neurosurg Psychiatry 1974; 37:841-847.
67. Van den NK, Vanderstraeten G, De MM, De WV. The neurophysiologic examination in organophosphate ester poisoning. Case report and review of the literature. Electromyogr Clin Neurophysiol 1991; 31:507-511.
68. De Wilde V, Vogelaers D, Colardyn F, Vanderstraeten G, Van Den Neucker K, De Bleecker J, De Reuck J, Van den Heede M. Postsynaptic neuromuscular dysfunction in organophosphate induced intermediate syndrome. Klin Wochenschr 1991; 69:177-183.
69. Shailesh KK, Pais P, Vengamma B, Muthane U. Clinical and electrophysiological study of intermediate syndrome in patients with organophosphorus poisoning. J Assoc Physicians India 1994; 42:451-453.
70. Poojara L, Vasudevan D, Arun Kumar A, Kamat V. Organophosphate poisoning: diagnosis of Intermediate syndrome. Indian J Crit Care Med 2003; 7:94-102.